Generic filters
Filter by input type
Select all
News
Pages
Events
Filter by category
Select all
AI ANALYTICS
Mobile Apps and Internet of Things
Advancement of science
big data
Connected communities
Coronavirus
Courses and training
DIAGNOSIS
Initial Editorial
Editorials
A world in the cloud
Events
Infographics
Artificial Intelligence and Science
IoT Apps
News
Digital platforms
Social networks
Review of scientific publications
Course Summary
Synopsis of essay
Overview of reference frames
Synopsis of recent publications
Use of Digital Platforms
Generic filters
Filter by input type
Select all
News
Pages
Events
Filter by category
Select all
AI ANALYTICS
Mobile Apps and Internet of Things
Advancement of science
big data
Connected communities
Coronavirus
Courses and training
DIAGNOSIS
Initial Editorial
Editorials
A world in the cloud
Events
Infographics
Artificial Intelligence and Science
IoT Apps
News
Digital platforms
Social networks
Review of scientific publications
Course Summary
Synopsis of essay
Overview of reference frames
Synopsis of recent publications
Use of Digital Platforms
Mayo Clinic program will support four Artificial Intelligence startups

Mayor Clinic has an accelerator program for new health technology companies, the first cohort includes four startups and will last 20 weeks.

Mayo Clinic Platform_Accelerate is a program that supports startups related to technology and health. This Mayo Clinic accelerator program offers 20-week attention to early-stage Artificial Intelligence (AI) projects.

In addition, Mayo Clinic provides guidance through its subject matter experts on regulatory, clinical, technological and business terms, with an AI model. These experts include specialists from Google and Epic, who will provide their services to program participants through workshops.

In this sense, the selected companies will work with experts in data science to verify their AI models and evaluate a possible authorization from the Food and Drug Administration (FDA).

"New health technology companies are critical contributors to the innovation cycle," said John Halamka, president of the Mayo Clinic Platform. In addition, he explained that Mayo Clinic is excited to collaborate to solve problems and test solutions for the most complex problems in medicine today.

The first participating startups are:

  • Cliexa, which designs data-centric solutions for people with cardiovascular problems and chronic diseases.
  • Quadrant Health, which analyzes electronic health records and patient messages to predict potential health events before they occur.
  • ScienceIO aims to develop tools for process optimization in healthcare and reduce the administrative workload on physicians.
  • Seer Medical seeks to develop models for the diagnosis and management of epilepsy at home, and to create digital biomarkers that are capable of predicting seizures.

“We help participants take a crucial step in their growth trajectory by providing startups with a disciplined approach to model validation and clinical preparation to show product value,” said Eric Harnisch, Vice President of Partner Programs. from the Mayo Clinic Platform.

Participating startups will be evaluated to explore eligibility to partner with the Mayo Clinic Platform on future projects.

 

Additionally, Mayo Clinic Platform_Accelerate announced that the next cohort has an open waiting list and will begin in the summer of 2022.

Last Tweets

Digital Health Events

2022 November

Semana 1

Mon 31
tue 1
wed 2
Thu 3
Fri 4
Sat 5
Sun 6
Mon 7
tue 8
wed 9
Thu 10
Fri 11
Sat 12
Sun 13
Mon 14
tue 15
wed 16
Thu 17
Fri 18
Sat 19
Sun 20
Mon 21
tue 22
wed 23
Thu 24
Fri 25
Sat 26
Sun 27
Mon 28
tue 29
wed 30
Thu 1
Fri 2
Sat 3
Sun 4
  • No Events

  • No Events

  • No Events

  • No Events

  • No Events

Share

Digital Health in the world

  • — Science Brief: Omicron (B.1.1.529) Variant/CDC updates
    See more
  • —Coronavirus resource center/Johns Hopkins
    See more
  • — Epidemiological tracing of COVID-19 contacts / Johns Hopkins Course
    See more
  • — SARS-CoV-2 infection behavior / FCS calculator
    See more
  • — Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic/ Article The Lancet
    See more
  • —Genomic Epidemiology Tracker/GISAID
    See more
  • — Mexican Genomic Surveillance Consortium
    See more
mistake: This content is protected...